Raphael Pharmaceutical Inc. (RAPH) › Capital ExpendituresRaphael Pharmaceutical Inc. (RAPH) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.Fiscal YearCapital ExpendituresChange YoY2022$2.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share